S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
Log in
NASDAQ:SXTC

China SXT Pharmaceuticals Stock Forecast, Price & News

$0.58
-0.05 (-8.36 %)
(As of 01/15/2021 08:00 PM ET)
Add
Compare
Today's Range
$0.56
Now: $0.58
$0.63
50-Day Range
$0.29
MA: $0.36
$0.70
52-Week Range
$0.22
Now: $0.58
$1.48
Volume177,684 shs
Average Volume17.48 million shs
Market Capitalization$20.11 million
P/E RatioN/A
Dividend YieldN/A
Beta0.17
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. It offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. The company provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of May 2, 2020, it served 116 pharmaceutical companies, 56 pharmacies, and 76 hospitals. The company was founded in 2005 and is based in Taizhou, China.

MarketRank

Overall MarketRank

0.44 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SXTC
CUSIPN/A
CIKN/A
Phone86-523-8629-8290
Employees97

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.16 million
Book Value$0.27 per share

Profitability

Miscellaneous

Market Cap$20.11 million
Next Earnings DateN/A
OptionableNot Optionable
$0.58
-0.05 (-8.36 %)
(As of 01/15/2021 08:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SXTC News and Ratings via Email

Sign-up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











China SXT Pharmaceuticals (NASDAQ:SXTC) Frequently Asked Questions

How has China SXT Pharmaceuticals' stock been impacted by COVID-19?

China SXT Pharmaceuticals' stock was trading at $0.7799 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SXTC shares have decreased by 25.6% and is now trading at $0.58.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than China SXT Pharmaceuticals?

Wall Street analysts have given China SXT Pharmaceuticals a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but China SXT Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting China SXT Pharmaceuticals?

China SXT Pharmaceuticals saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 179,900 shares, an increase of 32.4% from the December 15th total of 135,900 shares. Based on an average daily volume of 2,800,000 shares, the days-to-cover ratio is presently 0.1 days.
View China SXT Pharmaceuticals' Short Interest
.

Who are some of China SXT Pharmaceuticals' key competitors?

What other stocks do shareholders of China SXT Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China SXT Pharmaceuticals investors own include (HEXO), iBio (IBIO), Remark (MARK), Aytu BioScience (AYTU), BOQI International Medical (BIMI), (COCP), My Size (MYSZ), Nabriva Therapeutics (NBRV), Sintx Technologies (SINT) and Sorrento Therapeutics (SRNE).

Who are China SXT Pharmaceuticals' key executives?

China SXT Pharmaceuticals' management team includes the following people:
  • Mr. Feng Zhou, Chairman, CEO & Interim CFO (Age 29, Pay $50k)
  • Dr. Jingzhen Deng, Chief Scientific Officer & COO (Age 61, Pay $50k)
  • Mr. Jun Zheng, Exec. Director (Age 44)

What is China SXT Pharmaceuticals' stock symbol?

China SXT Pharmaceuticals trades on the NASDAQ under the ticker symbol "SXTC."

How do I buy shares of China SXT Pharmaceuticals?

Shares of SXTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is China SXT Pharmaceuticals' stock price today?

One share of SXTC stock can currently be purchased for approximately $0.58.

How big of a company is China SXT Pharmaceuticals?

China SXT Pharmaceuticals has a market capitalization of $20.11 million and generates $5.16 million in revenue each year. China SXT Pharmaceuticals employs 97 workers across the globe.

What is China SXT Pharmaceuticals' official website?

The official website for China SXT Pharmaceuticals is www.sxtchina.com.

How can I contact China SXT Pharmaceuticals?

China SXT Pharmaceuticals' mailing address is 178 TAIDONG ROAD NORTH, TAIZHOU F4, 225300. The company can be reached via phone at 86-523-8629-8290 or via email at [email protected]

This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.